These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography. Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594 [TBL] [Abstract][Full Text] [Related]
3. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention. Feldkamp T; Kribben A Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention. McCullough P Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569 [TBL] [Abstract][Full Text] [Related]
6. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography. Fishman EK; Reddan D Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820 [TBL] [Abstract][Full Text] [Related]
7. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents]. Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695 [TBL] [Abstract][Full Text] [Related]
8. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Marenzi G; Lauri G; Campodonico J; Marana I; Assanelli E; De Metrio M; Grazi M; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL Am J Med; 2006 Feb; 119(2):155-62. PubMed ID: 16443418 [TBL] [Abstract][Full Text] [Related]
9. [Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches]. Shamkhalova MSh; Zaĭtseva NV; Kurumova KO; Shestakova MV; Deev AD; Matskeplishvili ST; Tugeeva EF; Buziashvili IuI Ter Arkh; 2009; 81(8):36-42. PubMed ID: 19799198 [TBL] [Abstract][Full Text] [Related]
10. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320 [TBL] [Abstract][Full Text] [Related]
11. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794 [TBL] [Abstract][Full Text] [Related]
12. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961 [TBL] [Abstract][Full Text] [Related]
14. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576 [TBL] [Abstract][Full Text] [Related]
15. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303 [TBL] [Abstract][Full Text] [Related]
19. [Contrast nephropathy and its prevention]. Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580 [TBL] [Abstract][Full Text] [Related]
20. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions. Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]